Drug intelligence / Profile preview

liquor carbonis distillate + narrowband ultraviolet B phototherapy

Development stage
Unknown
Lead developer
NeoStrata
Modality
Small Molecules
Administration
Topical
01

Overview

Liquor carbonis distillate (LCD) combined with narrowband ultraviolet B (NB-UVB) phototherapy is a therapeutic regimen primarily used for the treatment of moderate to severe psoriasis. This combination approach, often referred to as a modified Goeckerman regimen, utilizes the synergistic effects of topical coal tar and specific wavelengths of ultraviolet light. LCD, a coal tar preparation such as Psorent, is applied topically to the skin to exert anti-inflammatory and anti-proliferative effects, largely mediated through the activation of the aryl hydrocarbon receptor (AhR). This is followed by exposure to NB-UVB radiation (311–313 nm), which suppresses cutaneous cell-mediated immune responses and inhibits DNA synthesis in hyperproliferative keratinocytes. Clinical evidence suggests that the combination significantly reduces the time to skin clearance compared to NB-UVB monotherapy.

Brand names
Psorent
Other names
coal tar + NB-UVBLCD + NB-UVBmodified Goeckerman regimen
02

Targets

AHR (Aryl hydrocarbon receptor)DNA

Beyond the preview

Go deeper on liquor carbonis distillate + narrowband ultraviolet B phototherapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liquor carbonis distillate + narrowband ultraviolet B phototherapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call